Skip to main content
Clinical Trials/NCT03234816
NCT03234816CompletedPhase 4

Vasopressor Prophylaxis After Spinal Anesthesia: A Dose Finding Study

Cairo University1 site in 1 country270 target enrollmentStarted: August 2, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
270
Locations
1
Primary Endpoint
incidence of postspinal hypotension

Study Overview

Brief Summary

Norepinephrine has been recently introduced as a prophylactic vasopressor during Cesarean delivery with promising results ; However, the optimum dose for efficient prophylaxis with the least side effects is not known. In this study, we will compare three doses (0.05, 0.1, 0.15 mcg/Kg/min) of norepinephrine for prophylaxis against Post-Spinal hypotension during cesarean delivery.

Detailed Description

Maternal hypotension is a common complication after spinal anesthesia for cesarean delivery (CD). Using vasopressors have been considered a gold standard for prevention of post-spinal hypotension (PSH) during CD.

Norepinephrine (NE) is a potent vasopressor characterized by both α adrenergic agonistic activity in addition to a weak β adrenergic agonistic activity; thus, NE is considered a vasopressor with minimal cardiac depressant effect; these pharmacological properties would make NE an attractive alternative to phenylephrine and ephedrine (the most commonly used vasopressors in obstetric anesthesia).

Norepinephrine has been recently introduced as a prophylactic vasopressor during CD with promising results; However, the optimum dose for efficient prophylaxis with the least side effects is not known.

In this study, we will compare three doses (0.05, 0.1, 0.15 mcg/Kg/min) of norepinephrine for prophylaxis against PSH during CD.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • full term singleton pregnant women
  • Scheduled for elective Cesarean Delivery
  • Aged between 18 and 40 years

Exclusion Criteria

  • Cardiac morbidities
  • Hypertensive disorders of pregnancy,
  • Peripartum bleeding
  • Baseline systolic blood pressure (SBP) < 100 mmHg
  • Body mass index > 35

Arms & Interventions

- 0.05 mcg /Kg/min group

Experimental

will receive norepinephrine 0.05 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Bupivacaine (Drug)

- 0.05 mcg /Kg/min group

Experimental

will receive norepinephrine 0.05 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Norepinephrine 0.05 mcg /Kg/min (Drug)

- 0.1 mcg /Kg/min group

Experimental

will receive norepinephrine 0.1 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Norepinephrine 0.1 mcg /Kg/min (Drug)

- 0.1 mcg /Kg/min group

Experimental

will receive norepinephrine 0.1 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Bupivacaine (Drug)

- 0.15 mcg /Kg/min group

Experimental

will receive norepinephrine 0.15 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Norepinephrine 0.15 mcg /Kg/min (Drug)

- 0.15 mcg /Kg/min group

Experimental

will receive norepinephrine 0.15 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Bupivacaine (Drug)

Outcomes

Primary Outcomes

incidence of postspinal hypotension

Time Frame: 30 minutes after spinal anesthesia

The number of patients who develop hypotension (defined as decreased SBP less than 80% of the baseline reading during the period from intrathecal injection till delivery of the fetus) after spinal block divided by the total number in the group

Secondary Outcomes

  • heart rate(90 minutes after spinal anesthesia)
  • vomiting(120 minutes after spinal anesthesia)
  • nausea(120 minutes after spinal anesthesia)
  • ephedrine consumption(60 minutes after spinal anesthesia)
  • Atropine consumption(60 minutes after spinal anesthesia)
  • APGAR score(10 minutes after delivery)
  • incidence of severe postspinal hypotension(30 minutes after spinal anesthesia)
  • arterial blood pressure(90 minutes after spinal anesthesia)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Hasanin

Principal investigator, Lecturer of anesthesia and critical care medicine

Cairo University

Study Sites (1)

Loading locations...

Similar Trials